Skip to content
drillr.ai
Sign up

DTIL

Precision BioSciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$7.47
+1.36%
Ask drillr

  • Aug 6, 2026, 11:01 UTC

    Precision BioSciences reported its financial results for the second quarter ended June 30, 2026, and provided a business update on August 6, 2026.

    Source:

  • Jul 27, 2026, 00:00 UTC

    Precision BioSciences Inc announced that Alex Kelly will step down as Chief Operating Officer effective August 1, 2026, and Naresh Tanna will succeed him as Chief Financial Officer effective the same date.

  • Jun 16, 2026, 00:00 UTC

    Precision BioSciences amended its term loan agreement with Banc of California, extending the maturity date from June 30, 2027 to December 31, 2029.